ArticleBritish journal of pharmacology2018

Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.

Eef L Theunissen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.